1. Centers for Disease Control and Prevention: About Arthritis Disabilities and Limitations.. ], [ http://www.cdc.gov/arthritis/data_statistics/disabilities-limitations.htm ]
2. World Health Organization: The global burden of disease. 2004. update [], [ http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/ ]
3. Bondeson J, Blom AB, Wainwright S, Hughes C, Caterson B, van den Berg WB: The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis. Arthritis Rheum. 2010, 62: 647-657. 10.1002/art.27290.
4. Mimata Y, Kamataki A, Oikawa S, Murakami K, Uzuki M, Shimamura T, Sawai T: Interleukin-6 upregulates expression of ADAMTS-4 in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Int J Rheum Dis. 2012, 15: 36-44. 10.1111/j.1756-185X.2011.01656.x.
5. Edwards JC, Wilkinson LS, Soothill P, Hembry RM, Murphy G, Reynolds JJ: Matrix metalloproteinases in the formation of human synovial joint cavities. J Anat. 1996, 188: 355-360.